Diffusion tensor imaging increases ability to remove benign tumors in children.


December 4, 2009 - Operative plans for removing juvenile pilocytic astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with diffusion tensor imaging, or DTI, according to a new study published in last week's issue of the Journal of Neurosurgery: Pediatrics.

Operating on patients with deep-seated tumors such as JPA, a benign tumor most frequently observed in children and young adults in the thalamus, remains a neurosurgical challenge. Conventional imaging techniques, such as structural MRI, has helped to reveal major anatomical features of the brain, primary gray matter.

DTI, a variation of MRI, can help identify white matter, or nerve fiber bundles, using specific radio-frequency and magnetic field pulses to track the movement of water molecules of the brain. In most brain tissue, water molecules diffuse in all different directions. But they tend to diffuse along the length of axons, whose coating of white, fatty myelin holds them in. Scientists can create pictures of axons by analyzing the direction of water diffusion.

The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain. This information can maximize the potential of completely removing the tumor, while avoiding damage to the fiber bundles that are directly related to motor functions of the patient.

“This study of six children with thalamic JPA showed that using advanced MRI technology can help identify distorted nerve fiber bundles around brain tumors,” said Jeffrey H. Wisoff, M.D., director of the Division of Pediatric Neurosurgery at NYU Langone Medical Center. “This allows an otherwise inoperable tumor to be completely removed which can hopefully lead to a cure.”

The co-authors of the study include Yaron Moshel, M.D., Ph.D., of the department of neurosurgery, David J. Monoky, M.D., clinical assistant professor in the department of radiology and Robert E. Elliott, M.D., in the department of neurosurgery at NYU Langone Medical Center.

For more information: www.communications.med.nyu.edu


Related Content

News | Radiology Business

July 25, 2024 — Immunis, Inc., a clinical-stage biotech developing groundbreaking secretome therapeutics for age and ...

Time July 25, 2024
arrow
News | RSNA

July 23, 2024 — Professional registration is open for RSNA 2024, the world’s largest radiology forum. This year’s theme ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 23, 2024 — Researchers at the National Institutes of Health (NIH) found that an artificial intelligence (AI) model ...

Time July 23, 2024
arrow
News | Artificial Intelligence

July 17, 2024 — Hyperfine, a groundbreaking medical device company that has redefined brain imaging with the world’s ...

Time July 17, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | Clinical Trials

June 27, 2024 — Prenuvo, which makes whole-body MRI screening for early cancer detection and other diseases, has ...

Time June 27, 2024
arrow
News | Pediatric Imaging

June 25, 2024 — Rady Children’s Hospital-San Diego, one of the nation’s top pediatric health care systems, today ...

Time June 25, 2024
arrow
News | MRI Breast

June 12, 2024 — Royal Philips recently announced the 1,111th installation of its revolutionary BlueSeal 1.5T magnet ...

Time June 12, 2024
arrow
News | Radiology Business

May 29, 2024 — Strategic Radiology added a third California member to the nation’s leading coalition of independent ...

Time May 29, 2024
arrow
Subscribe Now